Evidence map›Paper›PMID 24564920›Full record

ReviewStem cell research & therapy2013

Building a microphysiological skin model from induced pluripotent stem cells.

Zongyou Guo, Claire A Higgins, Brian M Gillette, Munenari Itoh, Noriko Umegaki, Karl Gledhill, Samuel K Sia, Angela M Christiano

Abstract readReview
In one paragraph

Review in Stem cell research & therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Next generation human skin constructs as advanced tools for drug development.Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zongyou Guo
Claire A Higgins
Brian M Gillette
Munenari Itoh
Noriko Umegaki
Karl Gledhill
Samuel K Sia
Angela M Christiano

Funding

Understanding the Biology of Chronic Ulcers: Histological and Molecular Basis...P30AR044535 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BICKERS, DAVID RINSEY · 1997 to 2015
$6.9M
Modeling complex diseases using iPSC-derived skin constructsU18TR000561 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHRISTIANO, ANGELA M · 2012 to 2014
$1.0M
NCATS NIH HHS 5U18TR000561-02NCATS NIH HHS U18 TR000561NCATS NIH HHS U18TR000561NIAMS NIH HHS P30AR044535
6 · The paper itself

Abstract

The discovery of induced pluripotent stem cells (iPSCs) in 2006 was a major breakthrough for regenerative medicine. The establishment of patient-specific iPSCs has created the opportunity to model diseases in culture systems, with the potential to rapidly advance the drug discovery field. Current methods of drug discovery are inefficient, with a high proportion of drug candidates failing during clinical trials due to low efficacy and/or high toxicity. Many drugs fail toxicity testing during clinical trials, since the cells on which they have been tested do not adequately model three-dimensional tissues or their interaction with other organs in the body. There is a need to develop microphysiological systems that reliably represent both an intact tissue and also the interaction of a particular tissue with other systems throughout the body. As the port of entry for many drugs is via topical delivery, the skin is the first line of exposure, and also one of the first organs to demonstrate a reaction after systemic drug delivery. In this review, we discuss our strategy to develop a microphysiological system using iPSCs that recapitulates human skin for analyzing the interactions of drugs with the skin.

Indexed as

AnimalsCell DifferentiationFibroblastsHumansInduced Pluripotent Stem CellsKeratinocytesMelanocytesMicrofluidic Analytical TechniquesModels, BiologicalPharmaceutical PreparationsSkinSkin, ArtificialPharmaceutical Preparations

Identifiers

PMID24564920
PMCPMC4029476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.